Science Explorer Back to mapMap
Discussion
Company · Newton · United States

Akashi Therapeutics (United States)

Research works
2
▼ 100% vs 2018-21
Citations
19
9.1 per fractional work
Top-10% rate
0.5%
all institutions 10.0%
Open access
32%
world 40%
International
20%
world 18%
Akashi Therapeutics (United States)

Not ranked overall: Akashi Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Akashi Therapeutics (United States) work in?

In all years, 37% of research at Akashi Therapeutics (United States) is in Physical Sciences, 26% in Life Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (21%), Engineering (21%), Medicine (21%).

Life Sciences26%Physical Sciences37%Health Sciences21%Social Sciences16%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 6 fields, with their numbers
    1. Engineering021.1%
    2. Computer Science015.8%
    1. Biochemistry, Genetics and Molecular Biology021.1%
    2. Neuroscience05.3%
    1. Medicine021.1%
    1. Decision Sciences015.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Akashi Therapeutics (United States)?

    The most cited paper from Akashi Therapeutics (United States) is "GsMTx4-D provides protection to the D2.mdx mouse" (Christopher W. Ward, Frederick Sachs, Ernest D. Bush et al., 2018), with 30 citations. Next come "Pharmacology of manipulating lean body mass" (12) and "Development of laser interferometer for a sine-approximation method" (5).

    Most cited papers
    #PaperReleasedCitations
    1 GsMTx4-D provides protection to the D2.mdx mouse Christopher W. Ward, Frederick Sachs, Ernest D. Bush et al. · Neuromuscular Disorders Open access 21 Jul 2018 30
    2 Pharmacology of manipulating lean body mass Patricio V. Sepulveda, Ernest D. Bush, Keith Baar · Clinical and Experimental Pharmacology and Physiology Open access 14 Oct 2014 12
    3 Development of laser interferometer for a sine-approximation method Takashi Usuda, Eiji Furuta, Akihiro Ohta et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper 22 May 2002 5
    4 AT-300, a calcium modulator, improves muscle force production and decreases muscle degeneration in D2-mdx model of Duchenne muscular dystrophy E.W. Bush, Christopher W. Ward, Thomas M. Suchyna et al. · Neuromuscular Disorders 12 Sep 2017 2
    All 4 most cited papers, with filters and sorting

    Which research topics does Akashi Therapeutics (United States) publish most on?

    By volume: Scientific Measurement and Uncertainty Evaluation, Advanced Measurement and Metrology Techniques, Sensor Technology and Measurement Systems and Muscle Physiology and Disorders.

    1. 1 Scientific Measurement and Uncertainty Evaluation Statistics, Probability and Uncertainty 0 works
    2. 2 Advanced Measurement and Metrology Techniques Mechanical Engineering 0 works
    3. 3 Sensor Technology and Measurement Systems Computer Networks and Communications 0 works
    4. 4 Muscle Physiology and Disorders Molecular Biology 0 works
    5. 5 Exercise and Physiological Responses Rehabilitation 0 works
    6. 6 Knee injuries and reconstruction techniques Surgery 0 works
    7. 7 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
    8. 8 Adipose Tissue and Metabolism Physiology 0 works
    9. 9 Muscle activation and electromyography studies Biomedical Engineering 0 works
    10. 10 Histone Deacetylase Inhibitors Research Molecular Biology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available32.1%not open67.9%

    World: 40% of research is openly available.

    with international co-authors19.8%domestic only80.2%

    World: 18% is written across borders.

    How has Akashi Therapeutics (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    200520102015

    Other research institutions in Newton

    All research institutions in Newton

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Akashi Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.